MCM3AP and hepatocellular carcinoma: Upregulation of HAGLROS [54], PVT1 [56], LINC00160 [60], NEAT1 [70], HCG11 [78], and MCM3AP-AS [79] in cancers were associated with poor clinical outcomes in patients with HCC.